Epilepsy and Seizure News
Neurofeedback News
Bellevue Therapist Beverly Brashen, Ph.D. Offers Specialized Insomnia Treatment and Neurofeedback Therapy for Trauma and Chronic Sleep Disorders Across Greater Seattle -
The integrative therapist at beverlybrashen.com combines neurofeedback, CBT-I, somatic therapy, trauma-informed care, ...
Rewiring Your Brain: Neurofeedback Goes Mainstream -
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Will Strahl walked up to my door with a massive black briefcase in his ...
What Is Neurofeedback? -
Whenever I mention that neurofeedback helped me regain my life after my multiple brain injuries — or that I’m now a neurofeedback provider — the first reaction is to ask me, what is neurofeedback? I’m ...
Elite athletes enhance their performance with 'neurofeedback'—and you can get a device for $99 -
When you think of the training tools that professional athletes have at their disposal, high-tech sports equipment and state-of-the-art athletic facilities come to mind. But training for peak ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
Medical News Today
PubMed
Perampanel use in pediatric autoimmune encephalitis-related seizures and epilepsy: a retrospective case series -
CONCLUSION: In this small retrospective case series, seizure improvement was observed in some pediatric patients with AE-related seizures or epilepsy after PER administration, without serious adverse events. Because most patients received concomitant ASMs and immunotherapy, these findings should be interpreted as preliminary and hypothesis-generating.
Lateralized excitation-inhibition rebalance correlates with motor recovery following hemispheric surgery -
Hemispheric epilepsy surgery effectively achieves seizure control, yet post-operative motor recovery remains challenging. Whether motor compensation is linked to the excitation-inhibition balance in the unaffected hemisphere (UH) remains unclear. Using scalp EEG, we quantified the aperiodic exponent of the power spectrum as a non-invasive biomarker of cortical excitation-inhibition ratio (where...
Complement System-Mediated Immunomodulation in Epilepsy: From Pathogenesis to Therapeutic Opportunities -
Epilepsy is a prevalent neurological disorder characterized by recurrent seizures and aberrant neuronal hyperexcitability. Although several antiseizure medications are clinically available, current treatments are primarily symptomatic and fail to prevent epileptogenesis or disease progression. Moreover, nearly one-third of patients develop resistance to these drugs. The absence of effective dis...
Genetic analysis of self-limiting familial infantile epilepsy caused by PRRT2 variants in Indian patients -
CONCLUSION: Our study findings broaden the variant spectrum of PRRT2 in SeLFIE, while oxcarbazepine remains highly effective treatment for seizure control. Early-stage genetic analysis plays a crucial role in minimizing unnecessary diagnostic procedures and in guiding more effective disease management in SeLFIE patients.
Does genetic diagnosis influence long-term seizure and developmental outcomes in childhood developmental and epileptic encephalopathies? A longitudinal audit -
OBJECTIVE: To evaluate long-term seizure and developmental outcomes of childhood-onset developmental and epileptic encephalopathies (DEE) of presumed genetic etiology and to determine whether genetic diagnosis influences the electroclinical trajectory.
Virtual Screening and Zebrafish Phenotype-Based Evaluation Argues Against Repurposing 4-Phenylbutyrate for STXBP1-Related Disorders -
Syntaxin-binding protein 1 (STXBP1) mutations lead to severe epilepsy, intellectual disability, developmental delay, and movement disorder. Effective treatments for these conditions do not exist. Recent studies in Munc18-1 (STXBP1) C. elegans models demonstrate that 4-phenylbutyrate (4-PBA) or related pharmacological chaperones stabilize Munc18-1 protein levels and rescue locomotion deficits. T...
Science Daily